These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12522911)

  • 1. [Biological warfare. I. Anthrax, plague, tularemia].
    Christ W; Stein H
    Med Monatsschr Pharm; 2002 Dec; 25(12):406-17. PubMed ID: 12522911
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs and vaccines against biological weapons.
    Conn Med; 2001 Dec; 65(12):719-20. PubMed ID: 11797482
    [No Abstract]   [Full Text] [Related]  

  • 3. [Germs employed as biological weapons].
    Meyer CG; May J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Sep; 37(9):538-46. PubMed ID: 12215940
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteria as agents of biowarfare. How to proceed when the worst is suspected.
    Tjaden JA; Lazarus AA; Martin GJ
    Postgrad Med; 2002 Aug; 112(2):57-60, 63-4, 67-70. PubMed ID: 12198754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax, botulism and tularemia in Italy.
    Serraino D; Puro V; Bidoli E; Piselli P; Girardi E; Ippolito G
    Infection; 2003 Mar; 31(2):128-9. PubMed ID: 12749299
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia.
    Daya M; Nakamura Y
    Crit Care Clin; 2005 Oct; 21(4):747-63, vii. PubMed ID: 16168313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for clinical management of bioterrorism bacterial diseases: anthrax, plague, turalemia and brucellosis].
    Eiros Bouza JM; Bachiller Luque MR; Ortiz de Lejarazu R
    An Med Interna; 2003 Oct; 20(10):540-7. PubMed ID: 14585044
    [No Abstract]   [Full Text] [Related]  

  • 8. The USA preparing for bioterrorism: the role of Fort Detrick since 1970.
    Proctor RA
    WMJ; 2002; 101(2):20-4. PubMed ID: 12085492
    [No Abstract]   [Full Text] [Related]  

  • 9. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Biological" but deadly. Potential biological weapons].
    Schroeder I
    Anaesthesist; 2002 Jan; 51(1):50-2. PubMed ID: 11968178
    [No Abstract]   [Full Text] [Related]  

  • 11. [Germs and toxins in bioterrorism].
    Inoue N
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():81-91. PubMed ID: 12722194
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacillus anthracis, Francisella tularensis and Yersinia pestis. The most important bacterial warfare agents - review.
    Pohanka M; Skládal P
    Folia Microbiol (Praha); 2009; 54(4):263-72. PubMed ID: 19826916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioterrorism: introduction and major agents.
    Kemp C
    J Am Acad Nurse Pract; 2001 Nov; 13(11):483-91. PubMed ID: 11930512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Jet immunization with polyvalent vaccine against plague, tularemia, and anthrax].
    Loktev NA; Pilipenko VG; Basilova GI; Shchedrin VI; Lunina EA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jun; (6):109-10. PubMed ID: 7445856
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs and vaccines against biological weapons.
    Med Lett Drugs Ther; 1999 Feb; 41(1046):15-6. PubMed ID: 10050177
    [No Abstract]   [Full Text] [Related]  

  • 16. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism.
    Altman GB
    Nurs Manage; 2002 Jan; 33(1):43, 45-7. PubMed ID: 11984331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in the management of biologic and chemical warfare causalities.
    Joseph B; Brown CV; Diven C; Bui E; Aziz H; Rhee P
    J Trauma Acute Care Surg; 2013 Oct; 75(4):582-9. PubMed ID: 24064869
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioterrorism preparedness: a discussion of category-A agents.
    Nagarajan A; Duffis WA
    J S C Med Assoc; 2010 Jun; 106(3):123-8. PubMed ID: 23270043
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunopotentiation for bacterial biodefense.
    Skyberg JA
    Curr Top Med Chem; 2014; 14(18):2115-26. PubMed ID: 25373479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioterrorism: pathogens as weapons.
    Anderson PD; Bokor G
    J Pharm Pract; 2012 Oct; 25(5):521-9. PubMed ID: 23011963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.